Q1FY22 Earnings Presentation

7 8 Strides 門 5 Multi-dosage Facility At Chestnut Ridge, New York 6 Acquisition of world class multi-dosage facility at Chestnut Ridge, New York 1 2 3 4 Built over an area of ~200,000 sq ft, the site adds new growth capacities of 2 billion units for the US markets Site expands our capabilities into niche domains including Hormones, Nasal Sprays, Gels, Modified Release products, Liquids and Controlled Substances that mostly need to be manufactured in USA The facility has long history of successful USFDA inspections, site to risk mitigate our manufacturing footprint for the US markets by mirroring capacities at the facility in Bangalore Site strengthens our ability to service federal contracts with 100+ TAA compliant products in the combined portfolio Access to a strong technical talent pool having several years of manufacturing and new product launch experience Consolidating our West Palm Beach operations with much larger and multi-dosage site in Chestnut Ridge, New York to deliver manufacturing cost synergies

View entire presentation